RT Journal
A1 Grey A, Cundy T
T1 BOne density testing in older women
JF JAMA
JO JAMA
YR 2012
FD October 10
VO 308
IS 14
SP 1428
OP 1428
DO 10.1001/jama.2012.12814
UL http://dx.doi.org/10.1001/jama.2012.12814
AB 
However, they advocated for a one-size-fits-all approach to treatment in suggesting that the decision to individualize the retesting interval be predicated on the estimated point at which a patient with low bone mass reaches the intervention threshold of a 3% 10-year risk of hip fracture as recommended by the National Osteoporosis Foundation. This threshold is based on a cost-effectiveness analysis3 that has not been validated in clinical studies, and its application would mean that the majority of individuals would not benefit from the prescribed treatment.